These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12062624)

  • 21. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.
    Jackson A; Skwarchuk MW; Zelefsky MJ; Cowen DM; Venkatraman ES; Levegrun S; Burman CM; Kutcher GJ; Fuks Z; Liebel SA; Ling CC
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):685-98. PubMed ID: 11172950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of a rectal ultrasound probe on the separation between prostate and rectum in high-dose-rate brachytherapy.
    Rylander S; Buus S; Bentzen L; Pedersen EM; Tanderup K
    Brachytherapy; 2015; 14(5):711-7. PubMed ID: 26164752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perirectal seeds as a risk factor for prostate brachytherapy-related rectal bleeding.
    Mueller A; Wallner K; Merrick G; Ford E; Sutlief S; Cavanagh W; Butler W
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1047-52. PubMed ID: 15234038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Organ movements and dose exposures in teletherapy of prostate cancer using a rectal balloon.
    Elsayed H; Bölling T; Moustakis C; Müller SB; Schüller P; Ernst I; Willich N; Könemann S
    Strahlenther Onkol; 2007 Nov; 183(11):617-24. PubMed ID: 17960337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is intraoperative nomogram-based overplanning of prostate implants necessary?
    D'Souza WD; Lee HK; Palmer MB; Smith LG; Pollack A
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):462-7. PubMed ID: 12738321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inverse automated treatment planning with and without individual optimization in interstitial permanent prostate brachytherapy with high- and low-activity 125I.
    Pinkawa M; Maurer U; Mulhern A; Gagel B; Block T; Borchers H; Grieger J; Henkel T; Eble M
    Strahlenther Onkol; 2003 Jun; 179(6):417-22. PubMed ID: 12789469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refining prostate seed brachytherapy: Comparing high-, intermediate-, and low-activity seeds for I-125 permanent seed prostate brachytherapy.
    Delouya G; Bahary P; Carrier JF; Larouche RX; Hervieux Y; Béliveau-Nadeau D; Donath D; Taussky D
    Brachytherapy; 2015; 14(3):329-33. PubMed ID: 25630619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brachytherapy radiation doses to the neurovascular bundles.
    DiBiase SJ; Wallner K; Tralins K; Sutlief S
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1301-7. PubMed ID: 10725644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.
    Cheng JC; Peng LC; Chen YH; Huang DY; Wu JK; Jian JJ
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1010-8. PubMed ID: 14575832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
    Pickett B; Pouliot J
    Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of constipation on rectal dosimetry following prostate brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Dorsey JT
    Med Dosim; 2000; 25(4):237-41. PubMed ID: 11150696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy.
    Wallner K; Roy J; Harrison L
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):465-71. PubMed ID: 7751187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy.
    Corriveau J; Wallner K; Merrick G; True L; Cavanagh W; Sutlief S; Butler W
    Brachytherapy; 2003; 2(2):108-13. PubMed ID: 15062149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal Toxicity Prediction Not Influenced by Rectal Contour or Dose-Volume Histogram Definition.
    Brand DH; Brüningk SC; Wilkins A; Naismith O; Gao A; Syndikus I; Dearnaley DP; Hall E; van As N; Tree AC; Gulliford S
    Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1163-1173. PubMed ID: 37433374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostatic conformal brachytherapy: 125I/103Pd postoperative dosimetric analysis.
    Merrick GS; Butler WM; Dorsey AT; Walbert HL
    Radiat Oncol Investig; 1997; 5(6):305-13. PubMed ID: 9436248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rectum dose reduction and individual treatment plan optimization for high-dose-rate prostate brachytherapy.
    Bölling T; Moustakis C; Elsayed H; Müller SB; Weining C; Reinartz G; Ernst I; Willich N; Könemann S
    Brachytherapy; 2007; 6(4):280-5. PubMed ID: 17991624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate.
    Steenbakkers RJ; Deurloo KE; Nowak PJ; Lebesque JV; van Herk M; Rasch CR
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1269-79. PubMed ID: 14630261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New approach of ultra-focal brachytherapy for low- and intermediate-risk prostate cancer with custom-linked I-125 seeds: A feasibility study of optimal dose coverage.
    Brun T; Bachaud JM; Graff-Cailleaud P; Malavaud B; Portalez D; Popotte C; Aziza R; Lusque A; Filleron T; Ken S
    Brachytherapy; 2018; 17(3):544-555. PubMed ID: 29525514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of seed loading approaches in prostate brachytherapy.
    Butler WM; Merrick GS; Lief JH; Dorsey AT
    Med Phys; 2000 Feb; 27(2):381-92. PubMed ID: 10718143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difference in rectal dosimetry between pre-plan and post-implant analysis in transperineal interstitial brachytherapy for prostate cancer.
    Ishiyama H; Kitano M; Satoh T; Niibe Y; Uemae M; Fujita T; Baba S; Hayakawa K
    Radiother Oncol; 2006 Feb; 78(2):194-8. PubMed ID: 16414135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.